Literature DB >> 16782699

Caveolin-1 knockout alters beta-adrenoceptors function in mouse small intestine.

Ahmed F El-Yazbi1, Woo Jung Cho, Richard Schulz, Edwin E Daniel.   

Abstract

beta-Adrenoceptors are G protein-coupled receptors whose functions are closely associated with caveolae in the heart and cultured cell lines. In the gut, they are responsible, at least in part, for the mediation of the sympathetic stimulation that might lead to intestinal paralysis postoperatively. We examined the effect of caveolin-1 knockout on the beta-adrenoceptor response in mouse small intestine. The relaxation response to (-)-isoprenaline in carbachol-contracted small intestinal tissue segments was reduced in caveolin-1 knockout mice (cav1(-/-)) compared with their genetic controls (cav1(+/+)). Immunohistochemical staining showed that beta-adrenoceptor expression was similar in both strains in gut smooth muscle. Selective beta-adrenoceptor blockers shifted the concentration response curve (CRC) of (-)-isoprenaline to the right in cav1(+/+) intestine, but not in cav1(-/-), with greatest shift in case of the beta(3)-blocker, SR59230A. The CRC of the selective beta(3)-agonist BRL 37344 was also shifted to the right in cav1(-/-) compared with cav1(+/+). The cAMP-dependent protein kinase (PKA) inhibitor H-89 shifted the CRC of (-)-isoprenaline to the right in cav1(+/+) but not in cav1(-/-). H-89 reduced the relaxation due to forskolin and dibutyryl cAMP in cav1(+/+) but not in cav1(-/-), suggesting a reduction in PKA activity in cav1(-/-). In cav1(+/+), PKA was colocalized with caveolin-1 in the cell membrane, but PKA immunoreactivity persisted in cav1(-/-). Examination of PKA expression in the lipid raft-rich membrane fraction of the jejunum revealed reduced PKA expression in cav1(-/-) compared with cav1(+/+). The results of the present study show that the function of beta-adrenoceptors is reduced in cav1(-/-) small intestine likely owing to reduced PKA activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782699     DOI: 10.1152/ajpgi.00159.2006

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

1.  Kv1.5 association modifies Kv1.3 traffic and membrane localization.

Authors:  Rubén Vicente; Núria Villalonga; Maria Calvo; Artur Escalada; Carles Solsona; Concepció Soler; Michael M Tamkun; Antonio Felipe
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

Review 2.  Recent advances in small bowel diseases: Part II.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

3.  Increased PDE5 activity and decreased Rho kinase and PKC activities in colonic muscle from caveolin-1-/- mice impair the peristaltic reflex and propulsion.

Authors:  Sunila Mahavadi; Sayak Bhattacharya; Divya P Kumar; Chereena Clay; Gracious Ross; Hamid I Akbarali; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-24       Impact factor: 4.052

4.  Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction.

Authors:  Jean-François Jasmin; Giuseppe Rengo; Anastasios Lymperopoulos; Ratika Gupta; Gregory J Eaton; Kevin Quann; Donna M Gonzales; Isabelle Mercier; Walter J Koch; Michael P Lisanti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-04       Impact factor: 4.733

5.  NK receptors, Substance P, Ano1 expression and ultrastructural features of the muscle coat in Cav-1(-/-) mouse ileum.

Authors:  G Cipriani; Crenguta S Serboiu; Mihaela Gherghiceanu; Maria Simonetta Faussone-Pellegrini; Maria Giuliana Vannucchi
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

6.  Smooth muscle NOS, colocalized with caveolin-1, modulates contraction in mouse small intestine.

Authors:  Ahmed F El-Yazbi; Woo Jung Cho; Jonathan Cena; Richard Schulz; Edwin E Daniel
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.